Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
Description
CONCLUSIONS: NMV-rcan reduce all-cause hospitalization and mortality among patients with LC who have COVID-19.
